One of the potential targets may be the inhibition of the dipeptidyl peptidase 4 (DPP4) [41], which has been shown by Hollande et al. [42] to increase the chemokine CCL11-mediated eosinophil migration into breast cancer and hepatocellular carcinoma mouse models. This evidence concerns the gene CCL11 and hepatocellular carcinoma.